Compare KDP & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KDP | WAT |
|---|---|---|
| Founded | 1981 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4B | 32.7B |
| IPO Year | 2007 | 1996 |
| Metric | KDP | WAT |
|---|---|---|
| Price | $31.20 | $326.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 18 |
| Target Price | $35.06 | ★ $386.59 |
| AVG Volume (30 Days) | ★ 9.4M | 1.4M |
| Earning Date | 05-29-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.96% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | 1.27 | ★ 10.76 |
| Revenue | ★ $15,351,000,000.00 | $3,165,286,000.00 |
| Revenue This Year | $4.78 | $103.90 |
| Revenue Next Year | $3.77 | $11.12 |
| P/E Ratio | ★ $24.43 | $30.33 |
| Revenue Growth | 3.62 | ★ 6.99 |
| 52 Week Low | $25.03 | $275.05 |
| 52 Week High | $36.12 | $414.15 |
| Indicator | KDP | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 71.45 | 32.38 |
| Support Level | $26.61 | $281.33 |
| Resistance Level | $34.07 | $363.09 |
| Average True Range (ATR) | 0.69 | 12.35 |
| MACD | 0.17 | -1.36 |
| Stochastic Oscillator | 91.34 | 24.32 |
Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. The company controls production and route to market for its own brands through in-house manufacturing plants and distribution infrastructure and leverages these facilities to manufacture and distribute for third-party coffee and beverage brands via licensing and partnership agreements. The US and Canada make up 95% of revenue, with the rest from Mexico.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.